17 / 39
Page 74
Notes:
allied
academies
February 28-March 01, 2019 | Paris, France
Palliative Care, Obstetrics and Gynecology
Stroke and Clinical Trials
International Conference on
Joint Event on
International Conference on
&
Journal of Research and Reports in Gynecology and Obstetrics | Volume: 3
complicated vulvar patches in the absence of further clinical
examination. We never expect the nature of the disease until
receiving the histopathological and immunohistochemistry.
Herein, EMPDwas found tobe secondary urogenitalmalignancy
with distal invasion, classified as type III according to reported
authors. Treatment options include surgery, radiotherapy,
photodynamic therapy, topical immunomodulator (Imiquimod
5%) with or without Trastuzumab. Our patient was unfit for
these trials as long as the disease was extended, preferring
symptomatic treatment.
Conclusion:
chronic rebel itching may arise from multifactorial
possibility including tumoral etiology that included extra
mammary local or invaded Paget ’s disease. High clinical index
of suspicion with a thorough work up should be undertaken to
rule out secondary.
Speaker Biography
H Y Fanomezantsoa is currently working in the department of Secondary Care in Louis
Jaillon General Hospital, Saint Claude, France. Her research work includes Paget disease
associated with urogenital malignancy discovered at the invasive stage in a celibate patient
e:
faheyv1@gmail.com